SCHEMBL5347157

SCHEMBL5347157

N=C([O])NCc1ccc(C(F)(F)F)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 2/20 0.55
HDAC1 Q13547 2/20 0.55
HDAC2 Q92769 2/20 0.55
HDAC6 Q9UBN7 2/20 0.55
HDAC10 Q969S8 1/20 0.55
HDAC11 Q96DB2 1/20 0.55
HDAC8 Q9BY41 1/20 0.55
MTOR P42345 2/20 0.53
LSS P48449 1/20 0.51
MAPK14 Q16539 1/20 0.49
NAMPT P43490 1/20 0.49
IDO1 P14902 2/20 0.47
ALDH1A1 P00352 2/20 0.46
MEN1 O00255 1/20 0.46
GAA P10253 1/20 0.46
MAPT P10636 1/20 0.46
KMT2A Q03164 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
EPHX2 P34913 1/20 0.46
PPARG P37231 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4020664 0.81 IDO1 (0.56) HDAC3HDAC1HDAC2HDAC6HDAC10
SCHEMBL24575984 0.81 MTOR (0.69) HDAC3HDAC1HDAC2HDAC6HDAC10
SCHEMBL2186485 0.80 MTOR (0.48) HDAC3HDAC1HDAC2HDAC6HDAC10
Hydrochloric Acid SCHEMBL30996799 0.80 IDO1 (0.57) HDAC3HDAC1HDAC2HDAC6HDAC10
SCHEMBL1695141 0.79 MTOR (0.58) HDAC3HDAC1HDAC2HDAC6HDAC10
SCHEMBL2629356 0.78 LSS (0.59) HDAC3HDAC1HDAC2HDAC6HDAC10
SCHEMBL3897948 0.78 CYP2C9 (0.59) HDAC3HDAC1HDAC2HDAC6HDAC10
SCHEMBL21387743 0.78 HDAC3 (0.59) HDAC3HDAC1HDAC2HDAC6HDAC10
SCHEMBL17777671 0.76 IDO1 (0.50) HDAC3HDAC1HDAC2HDAC6HDAC10
SCHEMBL4576236 0.75 MTOR (0.54) HDAC3HDAC1HDAC2HDAC6HDAC10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007123818-A2 ORGANIC NITRIC OXIDE ENHANCING SALTS OF PROSTAGLANDINS, COMPOSITIONS AND METHODS OF USE NITROMED, INC. (US) 2007-11-01 WO disclosed